NYSE
PHR

Phreesia Inc

Health Information Services
Healthcare

Prices are adjusted according to historical splits.

Phreesia Inc Stock Price

Vitals

Today's Low:
$21.02
Today's High:
$22.185
Open Price:
$21.53
52W Low:
$21.02
52W High:
$40
Prev. Close:
$21.87
Volume:
449509

Company Statistics

Market Cap.:
$1.66 billion
Book Value:
4.92
Revenue TTM:
$301.40 million
Operating Margin TTM:
-54.37%
Gross Profit TTM:
$171.64 million
Profit Margin:
-53.89%
Return on Assets TTM:
-25.2%
Return on Equity TTM:
-50.38%

Company Profile

Phreesia Inc had its IPO on 2019-07-18 under the ticker symbol PHR.

The company operates in the Healthcare sector and Health Information Services industry. Phreesia Inc has a staff strength of 1,576 employees.

Stock update

Shares of Phreesia Inc opened at $21.53 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $21.02 - $22.19, and closed at $21.27.

This is a -2.74% slip from the previous day's closing price.

A total volume of 449,509 shares were traded at the close of the day’s session.

In the last one week, shares of Phreesia Inc have slipped by -29.38%.

Phreesia Inc's Key Ratios

Phreesia Inc has a market cap of $1.66 billion, indicating a price to book ratio of 4.6598 and a price to sales ratio of 6.8381.

In the last 12-months Phreesia Inc’s revenue was $301.40 million with a gross profit of $171.64 million and an EBITDA of $-144275008. The EBITDA ratio measures Phreesia Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Phreesia Inc’s operating margin was -54.37% while its return on assets stood at -25.2% with a return of equity of -50.38%.

In Q1.3333333333333, Phreesia Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 32.3%.

Phreesia Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-3.27 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Phreesia Inc’s profitability.

Phreesia Inc stock is trading at a EV to sales ratio of 5.3198 and a EV to EBITDA ratio of -8.7978. Its price to sales ratio in the trailing 12-months stood at 6.8381.

Phreesia Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$340.44 million
Total Liabilities
$84.87 million
Operating Cash Flow
$-15795000.00
Capital Expenditure
$5.84 million
Dividend Payout Ratio
0%

Phreesia Inc ended 2024 with $340.44 million in total assets and $0 in total liabilities. Its intangible assets were valued at $340.44 million while shareholder equity stood at $247.02 million.

Phreesia Inc ended 2024 with $0 in deferred long-term liabilities, $84.87 million in other current liabilities, 554000.00 in common stock, $-680382000.00 in retained earnings and $40.61 million in goodwill. Its cash balance stood at $127.68 million and cash and short-term investments were $127.68 million. The company’s total short-term debt was $7,528,000 while long-term debt stood at $8.06 million.

Phreesia Inc’s total current assets stands at $219.23 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $53.91 million compared to accounts payable of $7.95 million and inventory worth $820000.00.

In 2024, Phreesia Inc's operating cash flow was $-15795000.00 while its capital expenditure stood at $5.84 million.

Comparatively, Phreesia Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$21.27
52-Week High
$40
52-Week Low
$21.02
Analyst Target Price
$38.27

Phreesia Inc stock is currently trading at $21.27 per share. It touched a 52-week high of $40 and a 52-week low of $40. Analysts tracking the stock have a 12-month average target price of $38.27.

Its 50-day moving average was $29.01 and 200-day moving average was $31.82 The short ratio stood at 7.23 indicating a short percent outstanding of 0%.

Around 493.3% of the company’s stock are held by insiders while 9570.6% are held by institutions.

Frequently Asked Questions About Phreesia Inc

The stock symbol (also called stock or share ticker) of Phreesia Inc is PHR

The IPO of Phreesia Inc took place on 2019-07-18

Similar Industry Stocks (Health Information Services)

Last Price
Chg
Chg%
$15.85
-0.15
-0.94%
$32.53
0.39
+1.21%
Relx PLC ADR (RELX)
$33.93
-0.16
-0.47%
$57.58
-3.03
-5%
$17.58
-1.1
-5.89%
$0.03
-0
-1.69%
$5.09
-0.39
-7.12%
$12.23
-0.08
-0.61%
$218.3
-0.7
-0.32%
Ocugen Inc (OCGN)
$0.42
0
0%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients’ mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Wilmington, Delaware.

Address

434 Fayetteville Street, Raleigh, NC, United States, 27601